The group's principal activities are to enhance the performance of medical devices and bio materials through the innovative use of therapeutics. The group operates through two segments: medical device coatings/implants and therapeutics. Medical device coatings/implants comprise the research and development of drug loaded coatings for medical devices and drug loaded medical implants. Therapeutics comprises the research and development of pharmaceuticals for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis. On 31-Jan-2003, it acquired cohesion technologies inc.
Executive Information
Name
Title
Email
David Howard
Chmn.
N/A
Rui Avelar
Chief Medical Officer
N/A
Tom Bailey
CFO
N/A
David Hall
Chief Compliance Officer, Sr. VP - Government, Community Relations
